A novel chemical compound SINCRO with dual function in the STING-type I interferon and tumor cell death pathways.
Cancer science 2018 07 07() doi 10.1111/cas.13726 Abstract Recent years have seen a number of regulatory approvals for immune oncology or immunotherapies based on their ability to enhance anti-tumor immune responses....
Read More